Buffer ETFs: The "Defined Outcome" Has a Price Tag

In the spring of 2025, when stocks were selling off, investors did not just sell — they bought shields. Buffer ETFs took in $2.5 billion in March alone. The broader "outcome" ETF family they belong to went from roughly $5 billion in assets in 2019 to $181 billion by the end of 2024, and research firm Cerulli projects the buffer slice could quadruple by 2030. The pitch shows up in every drawdown: stay invested, keep a share of the upside, and fence off a defined strip of downside. It is the fastest-growing slice of the ETF industry, and the money keeps arriving. But the more a product is sold as protection with participation, the more it pays to ask what the "defined outcome" actually defines — and what you give up to get it.

The trade behind the name

A buffer ETF is not a stock fund that happens to be cautious. It is a one-year options trade on the S&P 500's price return. In the standard construction the fund buys the index's upside, buys a put that absorbs the first chunk of loss (the buffer, usually 9% to 10%, sometimes 15% or more), and pays for that put by selling a call that caps your gain. Both the cap and the buffer are set on the day a period opens and reset when it closes, usually twelve months later.

The engineering is the same funded collar a commodity producer runs: sell the ceiling to buy the floor, and you win only if the price stays inside the range. The name is honest in a narrow sense — the range is defined on day one. Everything else is market luck. At the start of the current calendar year, an iShares 10%-buffer fund reset with a 16.15% net cap; another series that reopened this spring during an elevated-volatility stretch quoted 18.39% net, the highest cap that suite has ever offered. Caps are not fixed in the prospectus. They are whatever the options market quotes on the day the period opens, and you are locked into that number, whatever the year does.

The invisible price tag

Here is where the marketing gets quiet. The buffer is not free. Its cost sits on four lines, and two of them are invisible on the sales page.

The cap is the obvious one — you simply do not keep the year's gains above it, and those years are common. The 2021 outcome period is the textbook case: the S&P 500's price return was 26.89%, every buffer fund on the shelf capped out, and the most protective funds returned less than 10%.

The second line is dividends, which most buyers never notice. These funds track the index's price return, not its payout, and their own prospectuses say so. The S&P 500 currently yields about 1.1%; historically the dividend ran 1.5% to 2%, and over the two decades before Morningstar ran the numbers, total return outpaced price return by roughly 2.2 percentage points a year. One PGIM buffer fund states the point bluntly: its performance "does not reflect the payment of dividends." An index fund holder compounds those dividends; a buffer holder does not, in any year, buffer or not.

The third line is the fee — about 0.79% annually for the flagship Innovator funds, against a few basis points for a plain index fund. Fee plus forgone dividend is roughly two percentage points a year before the cap has cost you a single point of upside.

The fourth line is the clock, and it is the one that quietly eats the product's promise. The cap and buffer hold only for an investor who buys on the opening day of the period and holds to its close. Buy after the market has run up and you have bought a cap that is partly spent; buy after a drop and you have already consumed the buffer. One PGIM prospectus spells out the edge cases: if the fund has fallen far enough, the buffer is effectively zero for a new buyer, and if it has risen, the remaining upside may be gone while the downside exposure stays. The "defined outcome" is defined for a day-one-to-year-end holder only. That is a workable contract for a disciplined buyer and a trap for an impulsive one — and the money tends to arrive right after the rout.

What the record shows

Russell Investments has tested what that price tag buys, and the answer is a narrow band of outcomes. Buffer funds have typically lagged the broader market by about 4% a year — the standing premium on the protection. History makes clear why. More than one-sixth of all twelve-month periods since 1928 saw the S&P 500 fall more than 10%, punching straight through a standard buffer; 2.83% of periods fell more than 35%, well past any shield; and in 17% of periods the index gained 25 points or more, gains the cap hands to the option buyer. A sharp rally caps you, a sharp crash hurts you, and a flat year quietly bills you — the fund pays its fee, forgoes the dividend, and returns roughly nothing while the cash investor earns interest.

The tool works precisely when the year lands inside its range. From July 2021 through June 2022 the S&P 500's price return was negative 11.9%, a bruising twelve months for anyone unhedged; a buffer fund carrying a 15% buffer finished down only 0.92%. The shield did exactly what it was built to do. The problem is scope, not construction: these funds are engineered for moderate swings — the index down less than the buffer or up less than the cap — and marketed as if they covered all of them.

There is a behavioral pattern worth naming, because it costs real money. Demand spikes precisely in the fear spikes — the $2.5 billion month in March 2025, and the shift in April of that year when tariff panic pushed investors out of 9%–15% buffers into 15%–40% ones. But the terms are not negotiable: the options market quotes them on reset day, and the buyer who shows up mid-panic takes whatever fear is priced into the market that day. If there is an edge here at all, it belongs to the buyer who chooses the reset date whose terms look fair — not the one who joins the stampede.

What it is actually for

None of this makes the product worthless. It makes it a defined-range shield with a defined buyer. It is not a bond: there is no coupon, a catastrophic year can still take your money beyond the buffer, and it does not rally when stocks fall the way a real bond sleeve does. Replace your bond allocation with it and you have swapped a diversifier for a derivative on the same index you already own. What it genuinely does is convert one year of fear into a knowable range — money you will need at a date, or an investor who has historically panic-sold in drawdowns, may be better served by paying for that conversion than by selling at the bottom. That is the honest case, and it is a case about behavior and dates, not about improving your long-run compound.

Buy the range as the product, not as stocks with a shield bolted on. Buy at a period's opening, hold to its close, and only for money you would otherwise de-risk. If the year lands inside the range, the collar earned its keep. If the index is flat, far up, or down through the buffer, you have paid the fee, the dividend, and the sacrificed upside for coverage you did not use. The real price is compounding: most of the S&P 500's long-run edge over bonds comes from compounding total returns, and a cap trades that compounding away every single year. A buffer ETF makes one specific year's outcome knowable in advance — buy it only for the years you need that to be true.